Latest Dementia and Alzheimer’s Research News
The following are summaries related to new research on various dementia and Alzheimer’s disease studies and reports.
Proton Pump Inhibitors Do Not Cause Alzheimer’s or Dementia
A new study published in the Journal of the American Geriatrics Society looked at the safety of Proton Pump Inhibitors (PPIs) and any risks they may pose for dementia, mild cognitive impairment, or Alzheimer’s disease.
Previous reports have indicated a link between PPIs – medications used to manage ulcers and reflux disease – and the increased risk of Alzheimer’s and dementia.
The researchers looked at data from the National Alzheimer’s Coordinating Center (NACC) database from 2005 to 2015. The information came from people who are 50 and older who had either normal brain function or mild cognitive impairment, and the researchers noted their use of PPIs.
Of the 10,000 participants:
- 73% never used PPIs
- 18% used them occasionally
- 8% were using them often
The people taking PPIs were also using medications for treating sleep disorders, incontinence, and depression. All of these medications are known to be linked to cognitive impairment.
Interestingly, there was decreased risk of cognitive decline in the patients taking PPIs and the researchers indicated further investigation was needed to explain the decline.
Research Shows Gaps in Healthcare in Alzheimer’s Patients Who Live Alone
A report in the Journal of Alzheimer’s Disease found that 46% of people with Alzheimer’s in Sweden live alone and are primarily older women.
Proposing the idea that Alzheimer’s patients who are living alone may not be receiving the same adequate health care and treatment as those who live someone.